A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)
Trial details
- Registry ID
- NCT05107128
- Phase
- Phase 2
Drug identity checked against registry records
| No regulatory events match this view.This does not mean no FDA events have occurred. |